RAS:RAF proximity ligation assay may predict response to KRASG12C inhibitors in NSCLC

被引：1
|
作者：
Kato, Ryoji [1 ]
Solanki, Hitendra S. [1 ]
Imbody, Denis [1 ]
Majumder, Anurima [1 ]
Stern, Yaakov [1 ]
Bridenstine, Liznair [1 ]
Johnson, Joseph [1 ]
Haura, Eric B. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
MOLECULAR CANCER RESEARCH | 2023年 / 21卷 / 05期
关键词：
D O I：
10.1158/1557-3125.RAS23-A001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A001
引用
收藏
页数：1
相关论文
共 50 条
  • [1] High RAS-RAF binding as assessed via proximity ligation assay is associated with sensitivity to KRASG12C inhibitors in NSCLC
    Kato, Ryoji
    Solanki, Hitendra S.
    Imbody, Denis
    Majumder, Anurima
    Stern, Yaakov
    Bridenstine, Liznair
    Gundlapalli, Harika
    Aronchik, Ida
    Johnson, Joseph
    Haura, Eric B.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [2] In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer
    Kato, Ryoji
    Solanki, Hitendra S.
    Ozakinci, Hilal
    Desai, Bina
    Gundlapalli, Harika
    Yang, Yu Chi
    Aronchik, Ida
    Singh, Mallika
    Johnson, Joseph
    Marusyk, Andriy
    Boyle, Theresa A.
    Haura, Eric B.
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1150 - 1162
  • [3] KRASG12C inhibitors on the horizon
    Cagir, Ali
    Azmi, Asfar S.
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (09) : 923 - 925
  • [4] TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC
    Tammaccaro, Salvina Laura
    Prigent, Philippe
    Le Bail, Jean-Christophe
    Dos-Santos, Odette
    Dassencourt, Laurent
    Eskandar, Myriam
    Buzy, Armelle
    Venier, Olivier
    Guillemot, Jean-Claude
    Veeranagouda, Yaligara
    Didier, Michel
    Spanakis, Emmanuel
    Kanno, Tokuwa
    Cesaroni, Matteo
    Mathieu, Stephane
    Canard, Luc
    Casse, Alhassan
    Windenberger, Fanny
    Calvet, Loreley
    Noblet, Laurence
    Sidhu, Sukhvinder
    Debussche, Laurent
    Moll, Jurgen
    Valtingojer, Iris
    PHARMACEUTICALS, 2023, 16 (04)
  • [5] Resistance looms for KRASG12C inhibitors
    Aaron N. Hata
    Alice T. Shaw
    Nature Medicine, 2020, 26 : 169 - 170
  • [6] Resistance looms for KRASG12C inhibitors
    Hata, Aaron N.
    Shaw, Alice T.
    NATURE MEDICINE, 2020, 26 (02) : 169 - 170
  • [7] Mechanisms of Resistance to KRASG12C Inhibitors
    Dunnett-Kane, Victoria
    Nicola, Pantelis
    Blackhall, Fiona
    Lindsay, Colin
    CANCERS, 2021, 13 (01) : 1 - 14
  • [8] Dueling KRASG12C Inhibitors Achieve Responses
    Caruso, Catherine
    Rose, Suzanne
    CANCER DISCOVERY, 2020, 10 (01) : 10 - 10
  • [9] Assessment of KRASG12C inhibitors for colorectal cancer
    Piazza, Gary A.
    Chandrasekaran, Preethi
    Maxuitenko, Yulia Y.
    Budhwani, Karim I.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
    Negrao, Marcelo V.
    Araujo, Haniel A.
    Lamberti, Giuseppe
    Cooper, Alissa J.
    Akhave, Neal S.
    Zhou, Teng
    Delasos, Lukas
    Hicks, J. Kevin
    Aldea, Mihaela
    Minuti, Gabriele
    Hines, Jacobi
    Aredo, Jacqueline V.
    Dennis, Michael J.
    Chakrabarti, Turja
    Scott, Susan C.
    Bironzo, Paolo
    Scheffler, Matthias
    Christopoulos, Petros
    Stenzinger, Albrecht
    Riess, Jonathan W.
    Kim, So Yeon
    Goldberg, Sarah B.
    Li, Mingjia
    Wang, Qi
    Qing, Yun
    Ni, Ying
    Do, Minh Truong
    Lee, Richard
    Ricciuti, Biagio
    Alessi, Joao Victor
    Wang, Jing
    Resuli, Blerina
    Landi, Lorenza
    Tseng, Shu-Chi
    Nishino, Mizuki
    Digumarthy, Subba R.
    Rinsurongkawong, Waree
    Rinsurongkawong, Vadeerat
    Vaporciyan, Ara A.
    Blumenschein, George R., Jr.
    Zhang, Jianjun
    Owen, Dwight H.
    Blakely, Collin M.
    Mountzios, Giannis
    Shu, Catherine A.
    Bestvina, Christine M.
    Garassino, Marina Chiara
    Marrone, Kristen A.
    Gray, Jhanelle E.
    Patel, Sandip Pravin
    CANCER DISCOVERY, 2023, 13 (07) : 1556 - 1571
12345